Skip to main content
Ali Zaidi, MD, Cardiology, New York, NY, The Mount Sinai Hospital

AliHussainyZaidiMD

Cardiology New York, NY

Adult Congenital Heart Disease, Echocardiography, Cardiothoracic Imaging

Director, Mount Sinai Adult Congenital Heart Disease Center Director, Academic Affairs, Childrens Heart Center, Mount Sinai Kravis Childrens Hospital Associate Professor, Medicine and Pediatrics, Icahn School of Medicine at Mount Sinai, NY

Overview of Dr. Zaidi

Dr. Ali Zaidi is a cardiologist in New York, NY and is affiliated with multiple hospitals in the area, including The Mount Sinai Hospital and Mount Sinai South Nassau. He received his medical degree from Aga Khan Medical College and has been in practice 18 years. He is one of 605 doctors at The Mount Sinai Hospital and one of 82 doctors at Mount Sinai South Nassau who specialize in Cardiology. He has more than 40 publications and over 500 citings.

Education & Training

  • Ohio State University Hospital
    Ohio State University HospitalFellowship, Cardiovascular Disease, 2006 - 2011
  • Aga Khan Medical College
    Aga Khan Medical CollegeClass of 1999
  • Penn State Milton S Hershey Medical Center
    Penn State Milton S Hershey Medical CenterResidency, Internal Medicine/Pediatrics

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2014 - 2025
  • OH State Medical License
    OH State Medical License 2006 - 2015
  • PA State Medical License
    PA State Medical License 2005 - 2006
  • American Board of Internal Medicine Cardiovascular Disease
  • American Board of Pediatrics Pediatric Cardiology
  • American Board of Internal Medicine Adult Congenital Heart Disease

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • A 22-Year-Old's Heart Stopped for 12 Minutes. Doctors Used Hypothermia to Help
    A 22-Year-Old's Heart Stopped for 12 Minutes. Doctors Used Hypothermia to HelpNovember 13th, 2019
  • AHN, Baylor Scott & White, and Johns Hopkins Researchers Confirm Effectiveness of New Immunotherapy Drug Combination for Gastroesophageal Cancer Treatment
    AHN, Baylor Scott & White, and Johns Hopkins Researchers Confirm Effectiveness of New Immunotherapy Drug Combination for Gastroesophageal Cancer TreatmentMarch 26th, 2024

Hospital Affiliations